GEN Exclusives

More »

GEN News Highlights

More »
Mar 26, 2008

Lilly Beefs Up Biomarker Analysis Deal with HistoRx

  • Eli Lilly has gained broader use of HistoRx’ tissue biomarker analysis technology through a three-year extension. The expanded deal allows Lilly to increase its use of the Aqua® platform beyond the specified programs detailed in the 2005 agreement.

    Under the new alliance, HistoRx will also develop customized Aqua analysis-based immunohistochemical assays for Lilly to use in drug discovery and development projects.

    HistoRx has the option to commercialize the assays and reagents developed during the course of the partnership for clinical use as predictive diagnostics.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Megamerger Dealzapoppin Poll

What company not in this week’s M&A headlines do you think will be at the center of a megamerger, acquisition, or partial selloff this year?